Bruce C. Cozadd

2009

In 2009, Bruce C. Cozadd earned a total compensation of $838.9K as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 8% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$205,300
Option Awards$189,260
Salary$442,729
Other$1,574
Total$838,863

Cozadd received $442.7K in salary, accounting for 53% of the total pay in 2009.

Cozadd also received $205.3K in non-equity incentive plan, $189.3K in option awards and $1.6K in other compensation.

Rankings

In 2009, Bruce C. Cozadd's compensation ranked 5,045th out of 9,885 executives tracked by ExecPay. In other words, Cozadd earned more than 49.0% of executives.

ClassificationRankingPercentile
All
5,045
out of 9,885
49th
Division
Manufacturing
1,806
out of 3,690
51st
Major group
Chemicals And Allied Products
368
out of 866
58th
Industry group
Drugs
229
out of 638
64th
Industry
Pharmaceutical Preparations
175
out of 446
61st
Source: SEC filing on June 14, 2012.

Cozadd's colleagues

We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2009.

2009

Robert Myers

Jazz Pharmaceuticals

President

2009

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

2009

Carol Gamble

Jazz Pharmaceuticals

General Counsel

2009

Samuel Saks

Jazz Pharmaceuticals

Chief Executive Officer

News

You may also like